Andrew Horwitz

An experienced R&D leader, Andrew joined Inscripta as Vice President, Synbio Products in December 2022 as part of the acquisition of Sestina Bio. At Sestina, Andrew established and managed the R&D effort, working with a talented team to develop a manufacturing-focused technical thesis and platform. Prior to that, Andrew spent a decade leading R&D efforts at Demetrix and Amyris.

Andrew holds a PhD from Harvard Medical School, was a Jane Coffin Childs Postdoctoral Fellow, and has a BA from Pomona College.